Samsara Bio Capital, LLC Hille Vax, Inc. Transaction History
Samsara Bio Capital, LLC
- $173 Million
- Q3 2024
A detailed history of Samsara Bio Capital, LLC transactions in Hille Vax, Inc. stock. As of the latest transaction made, Samsara Bio Capital, LLC holds 799,274 shares of HLVX stock, worth $1.49 Million. This represents 0.82% of its overall portfolio holdings.
Number of Shares
799,274
Previous 799,274
-0.0%
Holding current value
$1.49 Million
Previous $11.6 Million
87.83%
% of portfolio
0.82%
Previous 5.94%
Shares
5 transactions
Others Institutions Holding HLVX
# of Institutions
80Shares Held
36.8MCall Options Held
0Put Options Held
0-
Frazier Life Sciences Management, L.P. Menlo Park, CA10.6MShares$19.9 Million1.01% of portfolio
-
Tang Capital Management LLC San Diego, CA4.92MShares$9.2 Million0.74% of portfolio
-
Black Rock Inc. New York, NY2.09MShares$3.91 Million0.0% of portfolio
-
Franklin Resources Inc San Mateo, CA1.96MShares$3.66 Million0.0% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY1.88MShares$3.52 Million0.06% of portfolio
About HilleVax, Inc.
- Ticker HLVX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 33,427,200
- Market Cap $62.5M
- Description
- HilleVax, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel vaccines. It is developing HIL-214, a virus-like particle-based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis caused by norovirus infection. The company is headquartered in Boston, Massachusetts.